Log in to search using one of your social media accounts:

 

Do your eyes hurt after the solar eclipse? Here ’ s what you need to know.

So you looked directly at the sun while trying to watch the solar eclipse. Maybe you didn't read the warnings or couldn't get your hands on a pair of eclipse glasses. Or maybe you did have them but couldn't resist, just for a few seconds, staring straight at the sun with your naked eyes, experts be darned. […]Related:A heart transplant saved this 13-year-old boy’s life. But he died on his first day of school.Elderly couple got ‘deepest wish’ — to die together — in rare euthanasia caseTibetan Buddhism-based ‘compassion’ training for doctors targets burnout
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news

Related Links:

UCLA HealthDr. Mario DengFINDINGSAn experimental blood test developed at UCLA that uses gene activity data from immune cells was 93 percent accurate in predicting survival rates for people with advanced heart failure who had surgery to implant mechanical circulatory support devices.BACKGROUNDMechanical circulatory support devices, such as ventricular assist devices and temporary total artificial hearts, can be surgically implanted in people with advanced heart failure to help the heart ’s pumping function.But people with advanced heart failure often also suffer from multi-organ dysfunction syndrome, which can lead to...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
ng-Ha Lee Prolonged monitoring by cardiac electrocardiogram (ECG) sensors is useful for patients with emergency heart conditions. However, implant monitoring systems are limited by lack of tissue biocompatibility. Here, we developed an implantable ECG sensor for real-time monitoring of ventricular fibrillation and evaluated its biocompatibility using an animal model. The implantable sensor comprised transplant sensors with two electrodes, a wireless power transmission system, and a monitoring system. The sensor was inserted into the subcutaneous tissue of the abdominal area and operated for 1 h/day for 5 days using a w...
Source: Sensors - Category: Biotechnology Authors: Tags: Article Source Type: research
ConclusionsSupratherapeutic whole-blood tacrolimus trough concentrations are independently associated with the development of AKI in adult heart transplantation patients. More stringent dosing of tacrolimus early after transplantation may be critical in preserving the kidney function.
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Source Type: research
Mehra M. Challenges, diligence, and a breakthrough in donation after circulatory death in heart transplantation. J Heart Lung Transplant 2017;36(12):1319-1321.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
By DAVID SHAYWITZ, MD One word: implementation. Increasingly, I’m convinced that the underappreciated challenges of implementation describe the ever-expanding gap between the promise of emerging technologies (sensors, AI) and their comparatively limited use in clinical care and pharmaceutical research. (Updated disclosure: I am now a VC, associated with a pharma company; views expressed, as always, are my own.) Technology Promises Disruption Of Healthcare… Let’s start with some context. Healthcare, it is universally agreed, is “broken,” and in particular, many of the advances and conveniences...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Uncategorized Daimler Benz AG David Shaywitz Innovation Source Type: blogs
My coauthors and I  appreciate the interest in our study and the comments of Drs Adhyapak and Parachuri. We agree that our study focused on a previously underinvestigated patient cohort, namely those who in addition to having severe left ventricular dysfunction met criteria for advanced surgical therapies such as tra nsplant or ventricular assist device implantation. In contrast to many studies that simply used a left ventricular ejection fraction value less than 20% as an inclusion criterion, our study excluded those patients who had transient “hibernating” myocardium and those with stable cardiomyopathie...
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Acquired: Mechanical circulatory support: Letter to the editor Source Type: research
In a recent article,1 conventional coronary artery bypass grafting surgery was associated with excellent results, like transplantation and/or left ventricular assist device implantation, although coronary artery bypass grafting surgery was only offered to a highly selected group of patients who demonstrated left ventricle myocardial viability and appropriate coronary target vessels for coronary bypass. Moreover, the patients were evaluated by a team of physicians with a large amount of experience in the treatment of patients with end-stage heart failure.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Acquired: Mechanical circulatory support: Letter to the editor Source Type: research
Adhyapak and Parachuri  have rightly focused on the most remarkable conclusion of the recent article by Kawajiri and colleagues1—that advanced heart failure is not a contraindication to conventional cardiac surgery. This conclusion gives credence to the natural instincts of many cardiologists and surgeons to address ex isting pathology before considering replacement or assist strategies. Nevertheless, routinely incorporating an expected 12% (n = 16) in-hospital mortality into one's practice carries substantial reputational risks that may offset the benefits of taking on these types of cases—particular...
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Acquired: Mechanical circulatory support: Letter to the editor Source Type: research
Despite several interventions, both pharmacologic- and device-based, for the treatment of advanced heart failure following ischemic heart disease, the incidence is increasing in large proportions, mainly targeting a patient's productive years. Several novel molecular- and device-based therapies have been developed that show promising short-term results with no long-term benefits.1 Although most randomized controlled trials yield results that are disappointing or difficult to interpret, the seemingly neutral findings of these trials promote the need for further trials.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Acquired: Mechanical circulatory support: Letter to the editor Source Type: research
More News: Cardiology | Eyes | Health | Heart | Heart Transplant | Training | Transplant Surgery | Transplants | Universities & Medical Training | Warnings